How much profit has CKD made this year?
CKD has made 8.34 B JPY this year.
CKD Net Income 2024
CKD Net Income
8.34 B JPY
Ticker
6407.T
ISIN
JP3346800000
In 2024, CKD's profit amounted to 8.34 B JPY, a -43.62% increase from the 14.79 B JPY profit recorded in the previous year.
The CKD Net Income history
| YEAR | NET INCOME (undefined JPY) |
|---|---|
| 2027e | 19.91 |
| 2026e | 17.24 |
| 2025e | 12.96 |
| 2024 | 8.34 |
| 2023 | 14.79 |
| 2022 | 12.57 |
| 2021 | 5.27 |
| 2020 | 3.69 |
| 2019 | 4.79 |
| 2018 | 9.14 |
| 2017 | 6.96 |
| 2016 | 5.46 |
| 2015 | 6.01 |
| 2014 | 5.46 |
| 2013 | 2.45 |
| 2012 | 3.74 |
| 2011 | 4.58 |
| 2010 | 1.49 |
| 2009 | -2.85 |
| 2008 | 5.55 |
| 2007 | 7.54 |
| 2006 | 5.18 |
| 2005 | 3.92 |
CKD Revenue, EBIT, Net Income JP3346800000 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into CKD, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by CKD from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects CKD’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of CKD. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into CKD’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing CKD’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on CKD’s growth potential.
CKD Revenue, EBIT and net profit per share
| Date | CKD Revenue | CKD EBIT | CKD Net Income |
|---|---|---|---|
| 2027e | 184.93 B undefined | 0 undefined | 19.91 B undefined |
| 2026e | 172.26 B undefined | 0 undefined | 17.24 B undefined |
| 2025e | 152.79 B undefined | 0 undefined | 12.96 B undefined |
| 2024 | 134.43 B undefined | 13.11 B undefined | 8.34 B undefined |
| 2023 | 159.46 B undefined | 21.17 B undefined | 14.79 B undefined |
| 2022 | 142.2 B undefined | 17.88 B undefined | 12.57 B undefined |
| 2021 | 106.72 B undefined | 7.7 B undefined | 5.27 B undefined |
| 2020 | 100.72 B undefined | 5.23 B undefined | 3.69 B undefined |
| 2019 | 115.67 B undefined | 5.43 B undefined | 4.79 B undefined |
| 2018 | 115.7 B undefined | 12.47 B undefined | 9.14 B undefined |
| 2017 | 94.01 B undefined | 9.58 B undefined | 6.96 B undefined |
| 2016 | 88.12 B undefined | 8.11 B undefined | 5.46 B undefined |
| 2015 | 83.38 B undefined | 8.36 B undefined | 6.01 B undefined |
| 2014 | 75.49 B undefined | 7.88 B undefined | 5.46 B undefined |
| 2013 | 65.03 B undefined | 3.24 B undefined | 2.45 B undefined |
| 2012 | 72.8 B undefined | 6.07 B undefined | 3.74 B undefined |
| 2011 | 72.02 B undefined | 7.51 B undefined | 4.58 B undefined |
| 2010 | 50.04 B undefined | 339 M undefined | 1.49 B undefined |
| 2009 | 68.18 B undefined | 1.43 B undefined | -2.85 B undefined |
| 2008 | 93.71 B undefined | 9.49 B undefined | 5.55 B undefined |
| 2007 | 104.26 B undefined | 12.72 B undefined | 7.54 B undefined |
| 2006 | 84.31 B undefined | 8.96 B undefined | 5.18 B undefined |
| 2005 | 77.2 B undefined | 7.71 B undefined | 3.92 B undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2005 | 77.2 B JPY | 7.71 B JPY | 3.92 B JPY |
| 2006 | 84.31 B JPY | 8.96 B JPY | 5.18 B JPY |
| 2007 | 104.26 B JPY | 12.72 B JPY | 7.54 B JPY |
| 2008 | 93.71 B JPY | 9.49 B JPY | 5.55 B JPY |
| 2009 | 68.18 B JPY | 1.43 B JPY | -2.85 B JPY |
| 2010 | 50.04 B JPY | 339 M JPY | 1.49 B JPY |
| 2011 | 72.02 B JPY | 7.51 B JPY | 4.58 B JPY |
| 2012 | 72.8 B JPY | 6.07 B JPY | 3.74 B JPY |
| 2013 | 65.03 B JPY | 3.24 B JPY | 2.45 B JPY |
| 2014 | 75.49 B JPY | 7.88 B JPY | 5.46 B JPY |
| 2015 | 83.38 B JPY | 8.36 B JPY | 6.01 B JPY |
| 2016 | 88.12 B JPY | 8.11 B JPY | 5.46 B JPY |
| 2017 | 94.01 B JPY | 9.58 B JPY | 6.96 B JPY |
| 2018 | 115.7 B JPY | 12.47 B JPY | 9.14 B JPY |
| 2019 | 115.67 B JPY | 5.43 B JPY | 4.79 B JPY |
| 2020 | 100.72 B JPY | 5.23 B JPY | 3.69 B JPY |
| 2021 | 106.72 B JPY | 7.7 B JPY | 5.27 B JPY |
| 2022 | 142.2 B JPY | 17.88 B JPY | 12.57 B JPY |
| 2023 | 159.46 B JPY | 21.17 B JPY | 14.79 B JPY |
| 2024 | 134.43 B JPY | 13.11 B JPY | 8.34 B JPY |
| 2025e | 152.79 B JPY | 0 JPY | 12.96 B JPY |
| 2026e | 172.26 B JPY | 0 JPY | 17.24 B JPY |
| 2027e | 184.93 B JPY | 0 JPY | 19.91 B JPY |
CKD stock margins JP3346800000 ·
The CKD margin analysis displays the gross margin, EBIT margin, as well as the profit margin of CKD. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for CKD.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the CKD's sales revenue. A higher gross margin percentage indicates that the CKD retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the CKD's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the CKD's total revenue generated. When comparing the revenue margin year over year, investors can gauge the CKD's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the CKD. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the CKD's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
CKD Margin History
| CKD Gross margin | CKD Profit margin | CKD EBIT margin | CKD Profit margin |
|---|---|---|---|
| 2027e | 28.3 % | 0 % | 10.77 % |
| 2026e | 28.3 % | 0 % | 10.01 % |
| 2025e | 28.3 % | 0 % | 8.48 % |
| 2024 | 28.3 % | 9.75 % | 6.2 % |
| 2023 | 29.1 % | 13.28 % | 9.27 % |
| 2022 | 28.76 % | 12.57 % | 8.84 % |
| 2021 | 26.96 % | 7.21 % | 4.94 % |
| 2020 | 25.95 % | 5.19 % | 3.66 % |
| 2019 | 24.65 % | 4.69 % | 4.14 % |
| 2018 | 30.97 % | 10.78 % | 7.9 % |
| 2017 | 30.56 % | 10.19 % | 7.4 % |
| 2016 | 30.34 % | 9.2 % | 6.2 % |
| 2015 | 30.51 % | 10.03 % | 7.21 % |
| 2014 | 30.67 % | 10.44 % | 7.23 % |
| 2013 | 26.18 % | 4.99 % | 3.77 % |
| 2012 | 27 % | 8.33 % | 5.14 % |
| 2011 | 28.68 % | 10.43 % | 6.36 % |
| 2010 | 22.83 % | 0.68 % | 2.99 % |
| 2009 | 22.58 % | 2.09 % | -4.18 % |
| 2008 | 26.92 % | 10.13 % | 5.92 % |
| 2007 | 27.91 % | 12.2 % | 7.23 % |
| 2006 | 28.35 % | 10.62 % | 6.15 % |
| 2005 | 29.66 % | 9.98 % | 5.08 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2005 | 29.66 % | 9.98 % | 5.08 % |
| 2006 | 28.35 % | 10.62 % | 6.15 % |
| 2007 | 27.91 % | 12.2 % | 7.23 % |
| 2008 | 26.92 % | 10.13 % | 5.92 % |
| 2009 | 22.58 % | 2.09 % | -4.18 % |
| 2010 | 22.83 % | 0.68 % | 2.99 % |
| 2011 | 28.68 % | 10.43 % | 6.36 % |
| 2012 | 27 % | 8.33 % | 5.14 % |
| 2013 | 26.18 % | 4.99 % | 3.77 % |
| 2014 | 30.67 % | 10.44 % | 7.23 % |
| 2015 | 30.51 % | 10.03 % | 7.21 % |
| 2016 | 30.34 % | 9.2 % | 6.2 % |
| 2017 | 30.56 % | 10.19 % | 7.4 % |
| 2018 | 30.97 % | 10.78 % | 7.9 % |
| 2019 | 24.65 % | 4.69 % | 4.14 % |
| 2020 | 25.95 % | 5.19 % | 3.66 % |
| 2021 | 26.96 % | 7.21 % | 4.94 % |
| 2022 | 28.76 % | 12.57 % | 8.84 % |
| 2023 | 29.1 % | 13.28 % | 9.27 % |
| 2024 | 28.3 % | 9.75 % | 6.2 % |
| 2025e | 28.3 % | 0 % | 8.48 % |
| 2026e | 28.3 % | 0 % | 10.01 % |
| 2027e | 28.3 % | 0 % | 10.77 % |
CKD Aktienanalyse
What does CKD do?
The CKD Corporation is a Japanese company based in Kitakyushu, Japan. It was founded in 1943 and has since grown into a globally operating corporation in the fields of automation technology, mechanical engineering, and products for industrial applications. CKD has a long history of manufacturing products for the automation industry, starting with components for pneumatic systems and expanding to include hydraulic, electric, and electronic products. The company offers a wide range of products and solutions for automation tasks, including sensors, control systems, drives, and valves. CKD operates in various industries, including automotive, electronics, mechanical engineering, and aviation, with subsidiaries in countries such as the USA, China, Taiwan, Singapore, Malaysia, and Thailand. Important business areas for CKD include the production of pneumatic components, systems, and equipment, as well as semiconductor manufacturing machines. The company also produces systems for use in airplanes, such as pressure regulators. In summary, CKD Corporation is a globally operating company with a wide range of products and a strong presence in various industries. It specializes in automation technology and provides products and solutions for industrial applications, particularly in the areas of pneumatics, semiconductor manufacturing, and aviation. CKD holds a strong position in all of these industries and is an important supplier of products and systems. CKD ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding CKD's Profit Margins
The profit margins of CKD represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of CKD's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating CKD's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
CKD's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When CKD’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about CKD stock
How has the profit developed compared to last year?
The profit has increased by -43.62% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does CKD publish its earnings?
CKD publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of CKD?
The profits of CKD are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of CKD?
You can learn more about the earnings of CKD by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does CKD pay?
Over the past 12 months, CKD paid a dividend of 56 JPY . This corresponds to a dividend yield of about 2.04 %. For the coming 12 months, CKD is expected to pay a dividend of 59.52 JPY.
What is the dividend yield of CKD?
The current dividend yield of CKD is 2.04 %.
When does CKD pay dividends?
CKD pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of CKD?
CKD paid dividends every year for the past 23 years.
What is the dividend of CKD?
For the upcoming 12 months, dividends amounting to 59.52 JPY are expected. This corresponds to a dividend yield of 2.17 %.
In which sector is CKD located?
CKD is assigned to the 'Industry' sector.
Wann musste ich die Aktien von CKD kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of CKD from 12/1/2024 amounting to 30 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
When did CKD pay the last dividend?
The last dividend was paid out on 12/1/2024.
What was the dividend of CKD in the year 2023?
In the year 2023, CKD distributed 71 JPY as dividends.
In which currency does CKD pay out the dividend?
The dividends of CKD are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von CKD
Our stock analysis for CKD Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CKD Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.